Volume 3, Issue 3 (September 2017)                   Curr Med Mycol 2017, 3(3): 21-26 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Darabian S, Hashemi S J, Khodavaisy S, Sharifynia S, Kord M, Akbari Dana M, et al . Morphological changes and induction of antifungal resistance in Aspergillus fumigatus due to different CO2 levels. Curr Med Mycol. 2017; 3 (3) :21-26
URL: http://cmm.mazums.ac.ir/article-1-174-en.html
Abstract:   (989 Views)
Background and Purpose: Aspergillosis is one of the most common opportunistic fungal infections in immunocompromised and neutropenic patients. Aspergillus fumigatus (A. fumigatus) is the most common causative agent of this infection. Due to variable CO2 concentrations that pathogens are exposed to during the infection process and to understand the role of CO2, we examined the effects of various CO2 concentrations as one of the environmental factors on morphological changes and induction of antifungal resistance in A. fumigatus.
Materials and Methods: A. fumigatus strains were cultured and incubated under 1%, 3%, 5%, and 12% CO2 atmospheres, each time for one, two, and four weeks. The control culture was maintained for one week without CO2 atmosphere. Morphological changes were investigated and antifungal susceptibility test was performed according to the recommendations of the Clinical and Laboratory Standards Institute (CLSI) M38-A2 document. The results of different CO2 atmospheres were compared with that of the control sample.
Results: We found that 1%, 3%, 5%, and 12% CO2 atmospheres were associated with morphological colony changes. Macroscopically, the colonies were shallow dark green, smooth, crisp to powdery with reduced growth; microscopic examination revealed the absence of conidiation. The induction of antifungal resistance in the susceptible strains to itraconazole, voriconazole, and amphotericin B increased after exposure to 12% CO2 atmosphere and four weeks of incubation. The MIC values for itraconazole, voriconazole, and amphotericin B were 16 g/ml, 1 g/ml, and 16 g/ml, respectively. These values for the control group were 0.125 g/ml, 0.125 g/ml, and 2 g/ml, respectively.
Conclusion: Exposure to different CO2 atmospheres induced morphological changes in A. fumigatus, it seems to increase the MIC values, as well. In parallel, resistance to both itraconazole and voriconazole was also observed.

Full-Text [PDF 579 kb]   (320 Downloads)    
Type of Study: Original Articles | Subject: Medical Mycology
Received: 2017/12/4 | Accepted: 2018/01/17 | Published: 2018/02/17

1. Rocchi S, Reboux G, Millon L. Azole resistance with environmental origin: What alternatives for the future? J mycol med. 2015; 25(4):249-56. [DOI:10.1016/j.mycmed.2015.10.008]
2. Abdolrasouli A, Rhodes J, Beale MA, Hagen F, Rogers TR, Chowdhary A, et al. Genomic context of azole resistance mutations in Aspergillus fumigatus determined using whole-genome sequencing. MBio. 2015; 6(3):e00536 . [DOI:10.1128/mBio.00536-15]
3. Denning DW, Pleuvry A, Cole DC. Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults. Med mycol. 2013; 51(4):361-70. [DOI:10.3109/13693786.2012.738312]
4. Meersseman W, Lagrou K, Maertens J, Wijngaerden EV. Invasive aspergillosis in the intensive care unit. Clin Infect Dis. 2007; 45(2):205-16. [DOI:10.1086/518852]
5. Maertens JA,Blennow O, Duarte RF, Mu-oz P. The current management landscape: aspergillosis. J Antimicrob Chemother. 2016; 71(2):ii23-9. [DOI:10.1093/jac/dkw393]
6. Patterson TF, Thompson GR 3rd, Denning DW, Fishman JA,Hadley S, Herbrecht R, et al.Practice guidelines for the diagnosis and management of Aspergillosis: 2016 update by the infectious diseases society of America. Clin Infect Dis.2016; 63(4):e1-60. [DOI:10.1093/cid/ciw326]
7. Denning DW, Venkateswarlu K,Oakley KL, Anderson MJ, Manning NJ, Stevens DA, et al.Itraconazole resistancein Aspergillus fumigatus. Antimicrob Agents Chemother.1997;41(6):1364-8.
8. Seyedmousavi S, Hashemi SJ,Zibafar E,Zoll J, Hedayati MT, Mouton JW, et al. Azole-resistant Aspergillus fumigatus, Iran. Emerg Infect Dis.2013; 19(5):832-4. [DOI:10.3201/eid1905.130075]
9. Nabili M, Shokohi T, Moazeni M, Khodavaisy S, Aliyali M, Badiee P, et al. High prevalence of clinical and environmental triazole-resistant Aspergillus fumigatus in Iran: is it a challenging issue? J Med Microbiol.2016; 65(6):468-75. [DOI:10.1099/jmm.0.000255]
10. Snelders E, Rijs AJ, Kema GH, Melchers WJ, Verweij PE. Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles. Appl and environ microbiol. 2009; 75(12):4053-7. [DOI:10.1128/AEM.00231-09]
11. Gonçalves SS, Souza ACR, Chowdhary A, Meis JF, Colombo AL. Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus. Mycoses. 2016; 59(4):198-219. [DOI:10.1111/myc.12469]
12. Escribano P, Peláez T, Mu-oz P, Bouza E, Guinea J. Is azole resistance in Aspergillus fumigatus a problem in Spain? Antimicrob agents chemother. 2013; 57(6):2815-20. [DOI:10.1128/AAC.02487-12]
13. Chowdhary A, Kathuria S, Xu J, Meis JF. Emergence of azole-resistant Aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health. PLoS pathog. 2013; 9(10):e1003633. [DOI:10.1371/journal.ppat.1003633]
14. Shalhoub S, Luong M-L, Howard S, Richardson S, Singer L, Chaparro C, et al. Rate of cyp51A mutation in Aspergillus fumigatus among lung transplant recipients with targeted prophylaxis. J Antimicrob Chemother. 2015; 70(4):1064-7. [DOI:10.1093/jac/dku528]
15. Wang HC, Huang JC, Lin YH, Chen YH, Hsieh MI, Choi PC, et al. Prevalence, mechanisms, and genetic relatedness of the human pathogenic fungus Aspergillus fumigatus exhibiting resistance to medical azoles in the environment of Taiwan. Environ Microbiol.2018; 20(1):270-80 [DOI:10.1111/1462-2920.13988]
16. da Silva Ferreira ME, Capellaro JL, dos Reis Marques E, Malavazi I, Perlin D, Park S, et al. In vitro evolution of itraconazole resistance in Aspergillus fumigatus involves multiple mechanisms of resistance. Antimicrob agents chemother. 2004; 48(11):4405-13. [DOI:10.1128/AAC.48.11.4405-4413.2004]
17. Sheth CC, Johnson E, Baker ME, Haynes K, Mühlschlegel FA. Phenotypic identification of Candida albicans by growth on chocolate agar. Med mycol. 2005; 43(8):735-8. [DOI:10.1080/13693780500265998]
18. Hedayati M, Pasqualotto A, Warn P, Bowyer P, Denning D. Aspergillus flavus: human pathogen, allergen and mycotoxin producer. Microbiology. 2007; 153(6):1677-92. [